South Alamo Medical Group established a Health Informatics department in 2013 to aid in quality improvement by transitioning to a value-based payment models with insurance partners, as well as participating in public reporting of physician quality data to the Texas Immunization Registry (ImmTrac), and participating in federal quality improvement incentive programs, such as Centers of Medicare & Medicaid Services (CMS) Meaningful Use and the Group Provider Reporting Option (GPRO). South Alamo Medical Group facilities are Patient-Centered Medical Home Recognized at a Level 2 for years 2015-2018.
South Alamo Medical Group is committed to quality improvement to their patients. Some of the benefits of quality improvement through Health Informatics department are: 1) Improving efficiency, 2) Patient safety, and 3) Clinical outcomes using information technology through our Electronic Health Records (EHR) system. The Health Informatics team consists of Patient Care Representatives, Medical Assistants, Health Coaches, and Health Information analysts. Health Informatics team manages the Patient Portal that engages and empowers patients to play an active role in their health. Health Informatics also utilizes the Health Information Exchange, Healthcare Access San Antonio (HASA), to assist in improving the health of their patients.
On a monthly basis clinicians are measured on internal, meaningful use, and clinical quality measures. South Alamo Medical Group runs reports through their EHR, e-MDs Series Solutions, using National Quality Forum (NQF) measures and standards to serve as a critically important foundation for initiatives to enhance healthcare value, make patient care safer, and achieve better outcomes. For more information, visit NQF at http://www.qualityforum.org/Home.aspx.
|Clinical Quality Measures||July 2016- June 2017|
|DM2 A1C < 9.0 (NQF 0059)||83%|
|LDL-C < 100 (NQF 0064B)||54%|
|DM2 Eye Exam (NQF 0055)||33%|
|HTN Control (NQF 0018)||70%|
|B-Blocker Post MI (NQF 0070)||83%|
|Breast Cancer Screening (NQF 0031)||72%|
|Colorectal Cancer Screening (NQF 0034)||74%|
|Influenza Vaccine (NQF 0041)||64%|
|Pneumonia Vaccine (NQF 0043)||83%|
|Cervical Cancer Screening (NQF 0032)||55%|
|DTaP (Diptheria, Tetanus and Pertussis)||86%|
|MMR (Measles, Mumps, and Rubella)||94%|
|HiB (H Influenza Type B)||96%|
|HepB (Hepatitis B)||93%|
|VZV (Chicken Pox)||95%|
|PCV (Pneumococcal Conjugate)||86%|
|Hep A (Hepatitis A)||74%|
|Comb.1 (DtaP, IPV, MMR, VZV, HiB, Hep B)||81%|
|Comb.2 (DtaP, IPV, MMR, VZV, HiB, Hep B, PVC)||78%|
|Pharyngitis Testing for Children||86%|